C. van Krimpen

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)

Jolien M. Bueno-de-Mesquita, Wim H. van Harten, Valesca P. Retèl et al. · The Lancet Oncology · 2007 · 277 citations

Prognostic Biomarkers, Breast Oncology, Medicine +10

Validation of 70-gene prognosis signature in node-negative breast cancer

Jolien M. Bueno-de-Mesquita, Sabine C. Linn, Richard Keijzer et al. · Breast Cancer Research and Treatment · 2008 · 176 citations · Full text

Breast Oncology, Oncology, Medicine +7

Angiotensin II Receptor Blockade After Myocardial Infarction in Rats

Jos F.M. Smits, C. van Krimpen, Regien G. Schoemaker et al. · Journal of Cardiovascular Pharmacology · 1992 · 175 citations

Hypertension, Heart Failure, Angiotensin Ii +10

Expression of c-Met and Heparan-Sulfate Proteoglycan Forms of CD44 in Colorectal Cancer

Vera J.M. Wielenga, Robbert van der Voort, Taher E.I. Taher et al. · American Journal Of Pathology · 2000 · 87 citations · Full text

Tumor Biology, Oncology, Medicine +7

Angiotensin II Receptor Blockade After Myocardial Infarction in Rats: Effects on Hemodynamics, Myocardial DNA Synthesis, and Interstitial Collagen Content

Jos F.M. Smits, C. van Krimpen, Regien G. Schoemaker et al. · Journal of Cardiovascular Pharmacology · 1992 · 77 citations

Cardiac Muscle, Hypertension, Heart Failure +18